Table 2.

Changes in clinical parameters

	Before administration	After 6 months of administration	After 12 months of administration
AST (IU/L)	27.8±13.5	26.5±12.7	24.8±11.1
ALT (IU/L)	31.8±23.6	30.8±18.2	26.5±14.0
γ-GTP (IU/L)	44.7±42.0	48.0±49.6	45.7±51.8
CPK (IU/L)	109.6±57.3	109.8±53.0	109.2±69.3
hs-CRP (mg/dL)	0.13±0.18	0.11±0.15	0.10±0.13
HbA1c (%)	8.3±1.6	8.5±1.5	8.3±1.6

The results are shown as mean ± standard deviation.

No parameter showed a significant change during the course of this study.